KRAS and hepatoblastoma: Several groups, including ours, have demonstrated that some genetic variants in the LINC00673, NRAS, KRAS, TP53, HMGA2, miR-34b/c, YTHDF1, and WTAP genes were associated with hepatoblastoma susceptibility [7–12].